In AML patients treated by allogeneic hematopoietic transplantation, CD34+supermobilization is a negative prognostic factor

被引：0
|
作者：
Avola, Giuseppe [1 ]
Camuglia, Maria Grazia [1 ]
Milone, Giuseppe [1 ]
机构：
[1] Azienda Osped Policlin Vittorio Emanuele, Programma Trapianto Emopoiet, I-95100 Catania, Italy
来源：
LEUKEMIA RESEARCH | 2013年 / 37卷 / 07期
关键词：
ACUTE MYELOID-LEUKEMIA; PERIPHERAL-BLOOD; MOBILIZATION; RELAPSE; RISK;
D O I：
10.1016/j.leukres.2013.03.015
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：853 / 854
页数：2
相关论文
共 50 条
  • [31] CD34-selected allogeneic hematopoietic cell transplantation for chronic myeloid leukemia in the tyrosine kinase era
    Vaughn, John L.
    Brown, Samantha
    Papadopoulos, Esperanza B.
    Jakubowski, Ann A.
    Tamari, Roni
    Giralt, Sergio A.
    Ponce, Doris M.
    Cho, Christina
    Perales, Miguel-Angel
    Shaffer, Brian C.
    Gyurkocza, Boglarka
    BONE MARROW TRANSPLANTATION, 2022, 57 (11) : 1740 - 1742
  • [32] Geriatric nutritional risk index as a useful prognostic factor in second allogeneic hematopoietic stem cell transplantation
    Kaito, Satoshi
    Wada, Atsushi
    Adachi, Hiroto
    Konuma, Ryosuke
    Kishida, Yuya
    Nagata, Akihito
    Konishi, Tatsuya
    Yamada, Yuta
    Kumagai, Takuma
    Yoshifuji, Kota
    Mukae, Junichi
    Akiyama, Megumi
    Inamoto, Kyoko
    Toya, Takashi
    Igarashi, Aiko
    Najima, Yuho
    Muto, Hideharu
    Kobayashi, Takeshi
    Kakihana, Kazuhiko
    Ohashi, Kazuteru
    Sakamaki, Hisashi
    Doki, Noriko
    ANNALS OF HEMATOLOGY, 2020, 99 (07) : 1655 - 1665
  • [33] Scoring System Prognostic of Outcome in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome
    Shaffer, Brian C.
    Ahn, Kwang Woo
    Hu, Zhen-Huan
    Nishihori, Taiga
    Malone, Adriana K.
    Valcarcel, David
    Grunwald, Michael R.
    Bacher, Ulrike
    Hamilton, Betty
    Kharfan-Dabaja, Mohamed A.
    Saad, Ayman
    Cutler, Corey
    Warlick, Erica
    Reshef, Ran
    Wirk, Baldeep Mona
    Sabloff, Mitchell
    Fasan, Omotayo
    Gerds, Aaron
    Marks, David
    Olsson, Richard
    Wood, William Allen
    Costa, Luciano J.
    Miller, Alan M.
    Cortes, Jorge
    Daly, Andrew
    Kindwall-Keller, Tamila L.
    Kamble, Rammurti
    Rizzieri, David A.
    Cahn, Jean-Yves
    Gale, Robert Peter
    William, Basem
    Litzow, Mark
    Wiernik, Peter H.
    Liesveld, Jane
    Savani, Bipin N.
    Vij, Ravi
    Ustun, Celalettin
    Copelan, Edward
    Popat, Uday
    Kalaycio, Matt
    Maziarz, Richard
    Alyea, Edwin
    Sobecks, Ron
    Pavletic, Steven
    Tallman, Martin
    Saber, Wad
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (16) : 1864 - +
  • [34] THE TIME FACTOR AND THE ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
    Parovichnikova, E. N.
    Kuzmina, L. A.
    Vasilyeva, V. A.
    Pokrovskaya, O. S.
    Drokov, M. Yu.
    Lukyanova, I. A.
    Fidarova, Z. T.
    Gaponova, T. V.
    Troitskaya, V. V.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2024, 69 (03): : 276 - 284
  • [35] Outcomes of patients with AML and MDS who relapse or progress after reduced intensity allogeneic hematopoietic cell transplantation
    Pollyea, D. A.
    Artz, A. S.
    Stock, W.
    Daugherty, C.
    Godley, L.
    Odenike, O. M.
    Rich, E.
    Smith, S. M.
    Zimmerman, T.
    Zhang, Y.
    Huo, D.
    Larson, R.
    van Besien, K.
    BONE MARROW TRANSPLANTATION, 2007, 40 (11) : 1027 - 1032
  • [36] Graft Immune Cell Composition Associates with Clinical Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with AML
    Impola, Ulla
    Larjo, Antti
    Salmenniemi, Urpu
    Putkonen, Mervi
    Itala-Remes, Maija
    Partanen, Jukka
    FRONTIERS IN IMMUNOLOGY, 2016, 7
  • [37] Outcomes of patients with AML and MDS who relapse or progress after reduced intensity allogeneic hematopoietic cell transplantation
    D A Pollyea
    A S Artz
    W Stock
    C Daugherty
    L Godley
    O M Odenike
    E Rich
    S M Smith
    T Zimmerman
    Y Zhang
    D Huo
    R Larson
    K van Besien
    Bone Marrow Transplantation, 2007, 40 : 1027 - 1032
  • [38] Effect of Total Nucleated and CD34+ Cell Dose on Outcome after Allogeneic Hematopoietic Stem Cell Transplantation
    Remberger, Mats
    Torlen, Johan
    Ringden, E.
    Engstrom, Mats
    Watz, Emma
    Uhlin, Michael
    Mattsson, Jonas
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (05) : 889 - 893
  • [39] Oral complaints in patients with acute myeloid leukemia treated with allogeneic hematopoietic stem cell transplantation
    Wysocka-Slowik, Aleksandra
    Gil, Lidia
    Slebioda, Zuzanna
    Dorocka-Bobkowska, Barbara
    MEDICINA ORAL PATOLOGIA ORAL Y CIRUGIA BUCAL, 2021, 26 (05): : E642 - E650
  • [40] Wilms' tumor gene 1 is an independent prognostic factor for pediatric acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation
    Deng, Dao-Xing
    Wen, Juan-Juan
    Cheng, Yi-Fei
    Zhang, Xiao-Hui
    Xu, Lan-Ping
    Wang, Yu
    Yan, Chen-Hua
    Chen, Yu-Hong
    Chen, Huan
    Han, Wei
    Wang, Feng-Rong
    Wang, Jing-Zhi
    Qin, Ya-Zhen
    Liu, Kai-Yan
    Huang, Xiao-Jun
    Zhao, Xiao-Su
    Mo, Xiao-Dong
    BMC CANCER, 2021, 21 (01)
12345